热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse CD8a Antibody
产品名称：
PE anti-mouse CD8a Antibody
产品类别：
抗体
产品编号：
100707
产品应用：
100707
[价格]
规格 价格 库存
50µg ￥ 444 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  30. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  3. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  4. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  5. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  6. Sun L, et al. 2021. Cancer Cell. :. PubMed
  7. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  8. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  9. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  10. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  11. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  12. Chen X, et al. 2009. Hum Immunol. 70:79. PubMed
  13. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  14. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  15. Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed
  16. Sng XYX, et al. 2020. J Immunol. 204:3108. PubMed
  17. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  18. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  19. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  20. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  21. Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
  22. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  23. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  24. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  25. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  26. Diao L, et al. 2022. iScience. 25:105511. PubMed
  27. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  28. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  29. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  30. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  31. Ibrahim M, et al. 2016. J Evid Based Complementary Altern Med. 21: 171 - 176. PubMed
  32. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  33. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  34. van Erp EA, et al. 2019. Viruses. 0.811111111. PubMed
  35. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  36. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  37. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  38. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  39. N'guessan P, et al. 2011. Antioxid Redox Signal. 15:1693. PubMed
  40. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  41. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  42. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  43. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  44. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  45. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  46. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  47. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  48. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  49. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  50. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  51. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  52. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  53. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  54. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  55. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  56. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  57. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  58. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  59. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  60. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  61. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  62. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  63. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  64. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  65. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  66. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  67. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  68. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  69. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  70. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  71. Li J, et al. 2019. JCI Insight. 5. PubMed
  72. Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed
  73. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  74. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  75. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  76. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  77. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  78. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  79. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  80. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  81. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  82. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  83. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  84. Yang H, et al. 2022. Nutrients. 14:. PubMed
  85. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  86. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  87. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  88. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  89. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  90. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  91. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  92. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  93. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  94. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  95. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  96. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  97. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  98. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  99. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  100. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  101. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  102. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  103. Cho K, et al. 2021. iScience. 24:103117. PubMed
  104. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  105. Zhao X, et al. 2013. Int Immunopharmacol. 17:793. PubMed
  106. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  107. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  108. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  109. Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed
  110. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  111. Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed
  112. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  113. Chan WF, et al. 2022. Nat Commun. 13:5582. PubMed
  114. Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed
  115. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  116. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  117. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  118. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  119. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  120. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  121. Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed
  122. Manrique-Rincón A, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01150. PubMed
  123. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  124. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  125. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  126. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  127. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  128. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  130. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  131. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  132. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  133. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  134. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  135. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  136. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  137. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  138. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  139. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  140. Bristow CL, et al. 2021. Front Oncol. 11:739080. PubMed
  141. Li J, et al. 2020. Development. . PubMed
  142. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  143. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  144. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  145. Rodriguez-Sosa M, et al. 2004. Infect Immun. 72:4552. PubMed
  146. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  147. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  148. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  149. Zhang J, et al. 2018. Nature. 553:91. PubMed
  150. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  151. Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed
  152. Pai M, et al. 2016. JPEN J Parenter Enteral Nutr. 40: 383 - 391. PubMed
  153. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  154. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  155. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  156. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  157. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  158. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  159. Koide S, et al. 2022. iScience. 25:103603. PubMed
  160. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  161. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  162. Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed
  163. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  164. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  165. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  166. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  167. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  168. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  169. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  170. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  171. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  172. Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed
  173. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  174. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  175. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
  176. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  177. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  178. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  179. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  180. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  181. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  182. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  183. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  184. Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed
  185. Chavez JS, et al. 2022. Cells. 11:. PubMed
  186. Wang X, et al. 2022. Elife. 11:. PubMed
  187. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  188. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  189. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  190. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  191. LeBlanc P, et al. 2014. J Biol Chem. 289:7777. PubMed
  192. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  193. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  194. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  195. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  196. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  197. Gawish R, et al. 2022. Elife. 11:. PubMed
  198. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  199. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  200. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  201. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  202. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  203. Zeng A, et al. 2020. Oncol Rep. . PubMed
  204. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  205. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  206. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  207. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  208. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  209. Yang E, et al. 2015. Acta Biochim Biophys Sin. 47: 588-596. PubMed
  210. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  211. Lee YT, et al. 2018. PLoS One. 13:e0190868. PubMed
RRID
AB_312746 (BioLegend Cat. No. 100707) AB_312747 (BioLegend Cat. No. 100708)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线